Globe Life (NYSE:GL) Releases FY 2026 Earnings Guidance
by Scott Moore · The Cerbat GemGlobe Life (NYSE:GL – Get Free Report) updated its FY 2026 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 15.400-15.90 for the period, compared to the consensus estimate of 15.320. The company issued revenue guidance of -.
Analyst Upgrades and Downgrades
A number of research firms recently weighed in on GL. Texas Capital raised shares of Globe Life to a “strong-buy” rating in a report on Wednesday, March 18th. Weiss Ratings raised shares of Globe Life from a “hold (c+)” rating to a “buy (b)” rating in a report on Monday, April 13th. Wells Fargo & Company raised their price target on shares of Globe Life from $171.00 to $172.00 and gave the company an “overweight” rating in a report on Friday, April 10th. Keefe, Bruyette & Woods reissued a “moderate buy” rating and set a $168.00 price objective on shares of Globe Life in a report on Thursday, March 26th. Finally, Evercore set a $157.00 price objective on shares of Globe Life in a report on Wednesday, February 18th. Two analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $172.11.
Get Our Latest Research Report on GL
Globe Life Stock Performance
Shares of NYSE GL traded up $0.44 during midday trading on Wednesday, hitting $151.36. The company’s stock had a trading volume of 568,844 shares, compared to its average volume of 500,687. Globe Life has a 1-year low of $111.13 and a 1-year high of $152.80. The firm’s fifty day moving average price is $143.17 and its 200-day moving average price is $139.20. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.07 and a current ratio of 0.07. The firm has a market cap of $11.87 billion, a P/E ratio of 10.75 and a beta of 0.47.
Globe Life (NYSE:GL – Get Free Report) last posted its quarterly earnings results on Wednesday, April 22nd. The company reported $3.43 EPS for the quarter, missing the consensus estimate of $3.49 by ($0.06). Globe Life had a net margin of 19.37% and a return on equity of 21.30%. The business had revenue of $1.56 billion during the quarter, compared to analyst estimates of $1.56 billion. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. On average, sell-side analysts forecast that Globe Life will post 15.27 EPS for the current fiscal year.
Globe Life Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, May 1st. Stockholders of record on Friday, April 3rd will be issued a $0.33 dividend. This is a boost from Globe Life’s previous quarterly dividend of $0.27. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $1.32 annualized dividend and a dividend yield of 0.9%. Globe Life’s dividend payout ratio (DPR) is presently 9.38%.
Insiders Place Their Bets
In other Globe Life news, CEO Frank M. Svoboda sold 12,500 shares of the company’s stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $144.78, for a total value of $1,809,750.00. Following the completion of the transaction, the chief executive officer owned 35,868 shares in the company, valued at approximately $5,192,969.04. This represents a 25.84% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Michael Clay Majors sold 30,000 shares of the company’s stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $146.89, for a total transaction of $4,406,700.00. Following the completion of the transaction, the executive vice president owned 47,066 shares of the company’s stock, valued at approximately $6,913,524.74. This trade represents a 38.93% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders sold 82,807 shares of company stock worth $12,041,286. Corporate insiders own 2.11% of the company’s stock.
Institutional Investors Weigh In On Globe Life
A number of hedge funds and other institutional investors have recently modified their holdings of GL. Parallel Advisors LLC raised its position in shares of Globe Life by 5.6% during the 4th quarter. Parallel Advisors LLC now owns 1,651 shares of the company’s stock worth $231,000 after buying an additional 87 shares in the last quarter. Guggenheim Capital LLC bought a new stake in shares of Globe Life during the 4th quarter worth about $229,000. Oxford Asset Management LLP bought a new stake in shares of Globe Life during the 4th quarter worth about $218,000. NorthRock Partners LLC bought a new stake in shares of Globe Life during the 3rd quarter worth about $208,000. Finally, Harvest Fund Management Co. Ltd raised its position in shares of Globe Life by 755.0% during the 3rd quarter. Harvest Fund Management Co. Ltd now owns 1,026 shares of the company’s stock worth $147,000 after buying an additional 906 shares in the last quarter. 81.61% of the stock is currently owned by institutional investors.
Globe Life Company Profile
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.